Abstract
Estrogen-dependent osteoarthritis (EDPOA) is a disease of perimenopausal-age women. Their manifestations are polyarticular pain with common co-morbidities (carpal tunnel syndrome, insomnia, fatigue, depression, and fibromyalgia). Based on dual role of glucocorticoids, its trophic action on the chondrocyte and its anti-inflammatory effect, we conducted a prospective interventional cohort study where we evaluate the efficacy and safety of oral low-dose GC in one hundred women with EDPOA. The pain intensity, number of tender joints as well as impact in co-morbidities were analyzed. We conclude that the use of low-dose GC in patients with EDPOA can be an effective and a safe therapeutic option. © 2013 Springer-Verlag.
Author supplied keywords
Cite
CITATION STYLE
Cañas, C. A., Osorio, C. J., Coronel, N., Cepeda, M. C., Izquierdo, J. H., & Bonilla-Abadía, F. (2014). Efficacy and safety of oral low-dose glucocorticoids in patients with estrogen-dependent primary osteoarthritis. Rheumatology International, 34(5), 733–735. https://doi.org/10.1007/s00296-012-2603-1
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.